IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 21 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 250 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 250 | +900.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 25 | -92.2% | 0.00% | – |
| Q1 2014 | $2,000 | – | 321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|